Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £48,258,000 of indicative cost of Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 5.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £6,594,840 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,906,000 |
| Nottingham University Hospitals Trust | £2,832,480 |
| University Hospital Southampton Nhs Ft | £2,642,640 |
| University Hpls Of Leicester Nhs Trust | £2,467,080 |
| North Bristol Nhs Trust | £2,336,880 |
| Sheffield Teaching Hospitals Nhs Trust | £1,774,080 |
| Portsmouth Hospitals Nhs Trust | £1,701,000 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,623,720 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,605,240 |
The primary-care picture
Mepolizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Mepolizumab medicine page.